<bill session="114" type="h" number="5763" updated="2019-11-15T21:43:11Z">
  <state datetime="2016-07-13">REFERRED</state>
  <status>
    <introduced datetime="2016-07-13"/>
  </status>
  <introduced datetime="2016-07-13"/>
  <titles>
    <title type="official" as="introduced">To clarify the treatment of certain DNA Specimen Provenance Assay tests as reasonable and necessary for the diagnosis or treatment of illness for coverage under the Medicare program.</title>
    <title type="short" as="introduced">Prostate Cancer Misdiagnosis Elimination Act of 2016</title>
    <title type="display">Prostate Cancer Misdiagnosis Elimination Act of 2016</title>
  </titles>
  <sponsor bioguide_id="B001275"/>
  <cosponsors>
    <cosponsor bioguide_id="C001072" joined="2016-07-13"/>
    <cosponsor bioguide_id="M001190" joined="2016-07-13"/>
    <cosponsor bioguide_id="P000604" joined="2016-07-13"/>
  </cosponsors>
  <actions>
    <action datetime="2016-07-13">
      <text>Introduced in House</text>
    </action>
    <action datetime="2016-07-13" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2016-07-13">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2016-08-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2016-07-13T04:00:00Z" status="Introduced in House">Prostate Cancer Misdiagnosis Elimination Act of 2016

This bill specifies that, unless the physician ordering a DNA Specimen Provenance Assay (DSPA) test recommends otherwise, a DSPA test furnished with respect to a positive prostate cancer biopsy shall be deemed to be medically necessary for purposes of Medicare.</summary>
</bill>
